Cargando…
The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population
PURPOSE: To determine the value of prebiopsy (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET)/computed tomography (CT) in discriminating malignant from benign vertebral bone lesions. MATERIALS AND METHODS: This retrospective study included 53 patients with 55 vertebral bone lesi...
Autores principales: | Loudini, Naila, Glaudemans, Andor W. J. M., Jutte, Paul C., Yakar, Derya, Kwee, Thomas C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360653/ https://www.ncbi.nlm.nih.gov/pubmed/32253470 http://dx.doi.org/10.1007/s00256-020-03426-8 |
Ejemplares similares
-
Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
por: Kasalak, Ömer, et al.
Publicado: (2017) -
Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia
por: Pijl, Jordy P., et al.
Publicado: (2020) -
Clinical and FDG-PET/CT Suspicion of Malignant Disease: Is Biopsy Confirmation Still Necessary?
por: Bent, Talitha, et al.
Publicado: (2021) -
FDG-PET/CT in infections: the imaging method of choice?
por: Glaudemans, Andor W. J. M., et al.
Publicado: (2010) -
Use of FDG-PET in differentiating benign from malignant compression fractures
por: Bredella, Miriam A., et al.
Publicado: (2008)